[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT1154777E - Medicamento para o tratamento de hipertensao arterial - Google Patents

Medicamento para o tratamento de hipertensao arterial

Info

Publication number
PT1154777E
PT1154777E PT00903681T PT00903681T PT1154777E PT 1154777 E PT1154777 E PT 1154777E PT 00903681 T PT00903681 T PT 00903681T PT 00903681 T PT00903681 T PT 00903681T PT 1154777 E PT1154777 E PT 1154777E
Authority
PT
Portugal
Prior art keywords
medication
treatment
arterial hypertension
arterial
hypertension
Prior art date
Application number
PT00903681T
Other languages
English (en)
Inventor
Harald Waldeck
Martin R Wilkins
Thormaehlen Dirk
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of PT1154777E publication Critical patent/PT1154777E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT00903681T 1999-02-16 2000-02-10 Medicamento para o tratamento de hipertensao arterial PT1154777E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19906310A DE19906310A1 (de) 1999-02-16 1999-02-16 Arzneimittel zur Behandlung von Bluthochdruck

Publications (1)

Publication Number Publication Date
PT1154777E true PT1154777E (pt) 2005-07-29

Family

ID=7897580

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00903681T PT1154777E (pt) 1999-02-16 2000-02-10 Medicamento para o tratamento de hipertensao arterial

Country Status (28)

Country Link
US (1) US6482820B2 (pt)
EP (1) EP1154777B1 (pt)
JP (1) JP2002537258A (pt)
KR (2) KR100797665B1 (pt)
CN (1) CN1198619C (pt)
AR (1) AR036864A1 (pt)
AT (1) ATE295174T1 (pt)
AU (1) AU773240C (pt)
BR (1) BR0008260A (pt)
CA (1) CA2362273C (pt)
CZ (1) CZ301499B6 (pt)
DE (2) DE19906310A1 (pt)
DZ (1) DZ3014A1 (pt)
ES (1) ES2238268T3 (pt)
HK (1) HK1042247B (pt)
HU (1) HUP0105491A3 (pt)
IL (1) IL144622A (pt)
NO (1) NO329588B1 (pt)
NZ (1) NZ514058A (pt)
PL (1) PL195283B1 (pt)
PT (1) PT1154777E (pt)
RU (1) RU2270679C2 (pt)
SK (1) SK287254B6 (pt)
TR (1) TR200102386T2 (pt)
TW (1) TWI221770B (pt)
UA (1) UA63032C2 (pt)
WO (1) WO2000048601A1 (pt)
ZA (1) ZA200105828B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
ATE406438T1 (de) * 1999-11-19 2008-09-15 Solvay Pharm Bv Menschliches homolog aus der familie der metalloproteasen
CA2357833C (en) * 2000-10-04 2005-11-15 Warner-Lambert Company Treatment of pulmonary hypertension using vasopressin antagonist
AR039352A1 (es) * 2001-05-18 2005-02-16 Solvay Pharm Gmbh Uso de un compuesto que tiene actividad inhibitoria combinada y concurrente con endopeptidasa neutra y metaloproteasa igs5.
CN100519561C (zh) * 2001-09-10 2009-07-29 泰博特克药品有限公司 制备六氢-呋喃并[2,3-b]呋喃-3-醇的方法
JP4384495B2 (ja) * 2002-01-16 2009-12-16 ソルベイ・フアーマシユーチカルズ・ベー・ブイ 固体のベンズアゼピン化合物の塩および医薬化合物の調製におけるそれらの使用
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
US7427611B2 (en) 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
MXPA06005547A (es) * 2003-11-18 2006-08-17 Solvay Pharm Gmbh Composiciones farmaceuticas para el tratamiento de disfuncion, enfermedad o trastorno renal, en particular, en pacientes diabeticos.
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
US7816347B2 (en) 2004-12-15 2010-10-19 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
US20070292503A1 (en) * 2006-06-16 2007-12-20 Gorissen Henricus R Oral pharmaceutical composition of poorly water-soluble active substance
US20070299054A1 (en) * 2006-06-22 2007-12-27 Rajesh Jain Oral pharmaceutical composition of a poorly water-soluble active agent
KR20100135729A (ko) * 2008-01-31 2010-12-27 반더빌트유니버시티 폐의 용태에 따른 치료 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749688A (en) * 1986-06-20 1988-06-07 Schering Corporation Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
EP0254032A3 (en) * 1986-06-20 1990-09-05 Schering Corporation Neutral metalloendopeptidase inhibitors in the treatment of hypertension
CA1337400C (en) * 1987-06-08 1995-10-24 Norma G. Delaney Inhibitors of neutral endopeptidase
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel

Also Published As

Publication number Publication date
WO2000048601A1 (de) 2000-08-24
ATE295174T1 (de) 2005-05-15
NZ514058A (en) 2001-09-28
HUP0105491A3 (en) 2002-08-28
BR0008260A (pt) 2001-11-06
ZA200105828B (en) 2002-07-15
CA2362273C (en) 2010-05-25
AU773240C (en) 2004-11-18
AU2547600A (en) 2000-09-04
JP2002537258A (ja) 2002-11-05
KR20070027719A (ko) 2007-03-09
SK10822001A3 (sk) 2002-03-05
CA2362273A1 (en) 2000-08-24
SK287254B6 (sk) 2010-04-07
RU2270679C2 (ru) 2006-02-27
CN1339966A (zh) 2002-03-13
AR036864A1 (es) 2004-10-13
HK1042247A1 (en) 2002-08-09
DZ3014A1 (fr) 2004-03-27
CZ20012672A3 (cs) 2002-02-13
HUP0105491A2 (en) 2002-06-29
CZ301499B6 (cs) 2010-03-24
NO329588B1 (no) 2010-11-15
DE50010284D1 (de) 2005-06-16
IL144622A (en) 2006-08-20
KR100797665B1 (ko) 2008-01-23
TR200102386T2 (tr) 2002-01-21
UA63032C2 (en) 2004-01-15
EP1154777B1 (de) 2005-05-11
PL195283B1 (pl) 2007-08-31
DE19906310A1 (de) 2000-08-17
PL350167A1 (en) 2002-11-18
AU773240B2 (en) 2004-05-20
CN1198619C (zh) 2005-04-27
US6482820B2 (en) 2002-11-19
HK1042247B (zh) 2005-09-23
EP1154777A1 (de) 2001-11-21
NO20013958L (no) 2001-10-15
KR20010101922A (ko) 2001-11-15
TWI221770B (en) 2004-10-11
NO20013958D0 (no) 2001-08-15
US20020052361A1 (en) 2002-05-02
ES2238268T3 (es) 2005-09-01

Similar Documents

Publication Publication Date Title
PT1154777E (pt) Medicamento para o tratamento de hipertensao arterial
EE200200172A (et) Ühendid isheemia ravimiseks
PT1147083E (pt) Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao
EE200200673A (et) Kinasoliini derivaadid kasvajate raviks
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
NO20021400L (no) Terapeutiske kinazolinderivater
FI20000863A (fi) Uusi hoitomenetelmä
PT1144395E (pt) Derivados de 2-aminobenzoxazinona para o tratamento da obesidade
FI20000564A (fi) Menetelmä nanolaminaattien valmistamiseksi
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
PT1143977E (pt) Derivados de 2-oxibenzoxazinona para o tratamento da obesidade
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
PT1206436E (pt) Retinoides para o tratamento de enfisema
NO20005179D0 (no) Medikament behandling
IS6137A (is) Meðhöndlun á hugsýkistruflunum
DE60032884D1 (de) Blutbehandlungssystem
NO20033804D0 (no) Karbamatforbindelser for behandling av smerte
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
DE60220220D1 (de) Blutbehandlungssystem
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20012106D0 (no) Middel for behandling av benpatobolisme
NO20020784D0 (no) Medikament for behandling av brudd
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais